TABLE 1

Risk effect of the detection of enterovirus RNA in serum for later development of clinical type 1 diabetes

Time periodOR95% CIP
Boys and girls
    Birth-before Aab6.21.8–21<0.004
    Birth-before 6 month period prior Aab3.10.4–22.4<0.27
    6 month period prior Aab7.71.9–31.5<0.004
Boys
    Birth-before Aab18.82.2–163.7<0.008
    Birth-before 6 month period prior Aab3.90.2–63.3<0.34
    6 month period prior Aab18.22.0–164.5<0.01
Girls
    Birth-before Aab2.60.5–12.3<0.24
    Birth-before 6 month period prior Aab2.40.2–39.7<0.53
    6 month period prior Aab3.10.4–21.8<0.26
  • 6 month period prior AAb, 6-month time window before autoantibody seroconversion; birth-before 6 month period prior Aab, time from birth to 6 months before the seroconversion to positivity for the first autoantibody; birth-before Aab, time from birth to the seroconversion to positivity for the first autoantibody.